Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
FathomX
Singaporean startup FathomX scores almost $2M to hasten breast cancer AI development
By
Adam Ang
|
05:02 am |
September 01, 2022
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.
